Subsequent studies demonstrated that although GLP-1r mRNA levels was reduced in samples harvested from inflamed sites of IBD patients and colitis mice (78), GLP-1 levels were increased in sera of IBD patients when compared with healthy controls (79, 80). This evidence concerns the gene GCG and inflammatory bowel disease.